QUIA Share Price Performance
SEK 0.0005
-0.00 (-85.71%)
Price SEK 0.0005
Share Pricen/a
Quia Pharma AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
QUIA Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Quia Pharma AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.017
- 40.00%
- -7,058.04%
- 0%
About QUIA
- Founded
- 2004
- Employees
- 2
- CEO
- WebsiteView website
Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company’s Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
